CFFC received a request to share information regarding a clinical trial investigating phage therapy for treating Pseudomonas aeruginosa. The request came from Pranita D. Tamma, M.D., M.H.S., Associate Professor of Pediatrics, at Johns Hopkins University School of Medicine. Here is an excerpt from her email:
I am a researcher involved in a clinical trial funded by the National Institute of Health (NIH) that is investigating the use of phage therapy as a potential treatment for adults living with cystic fibrosis colonized with Pseudomonas aeruginosa. The aim of the trial is to assess the safety and microbiological activity of phage in clinically stable CF individuals chronically colonized with P. aeruginosa with an FEV1 of at least 20%. We are seeking your assistance with disseminating awareness of this trial within the CF community.
The request was accompanied by a flyer that provides a brief description of the clinical trial including contact information. Click here to download Phage Clinical Trial Flyer. You can also get details on the trial using this link to ClinicalTrials.gov: A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa